Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials

Power Life Sciences

Status: Not yet enrolling

Conditions: Rhabdomyosarcoma

Study type: Observational

Funder types: Industry

Identifiers

NCT06029465

84447609

Details and patient eligibility

About

The study seeks to delve into the firsthand experiences of patients diagnosed with rhabdomyosarcoma who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals.

The data collected from this study will help improve future outcomes for all rhabdomyosarcoma patients as well as those in under-represented demographic groups.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of rhabdomyosarcoma
• Considered reliable, able to understand, and willing to perform all study procedures
• Signed Written Informed Consent

Exclusion criteria

• Currently enrolled in, have completed or have discontinued from a clinical trial involving an investigational drug
• Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
• Any serious and/or unstable pre-existing medical disorders

Trial design